CollPlant Biotechnologies (CLGN) Earnings Date & Reports
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics... Show more
CLGN is expected to report earnings to fall 32.61% to 15 cents per share on November 26
Q3'25
Est.
$0.16
Q2'25
Beat
by $0.37
Q1'25
Beat
by $0.47
Q4'24
Missed
by $0.06
Q3'24
Missed
by $0.09
The last earnings report on August 20 showed earnings per share of 23 cents, beating the estimate of -14 cents. With 21.23K shares outstanding, the current market capitalization sits at 30.26M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CLGN showed earnings on August 20, 2025. You can read more about the earnings report here.